http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1790382

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 95
issn 0960-9776
issueIdentifier 1
pageRange 89-95
publicationName Breast (Edinburgh, Scotland)
startingPage 89
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4f673a372207416d215f6367e0aefb8b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e172656619fc80f0d9b83b1e08d0536b
bibliographicCitation Laliotis A, Vrekoussis T, Kafousi M, Sanidas E, Askoxilakis J, Melissas J, Mavroudis D, Castanas E, Stathopoulos EN. Immunohistochemical study of pElk-1 expression in human breast cancer: association with breast cancer biologic profile and clinicopathologic features. Breast. 2013 Feb;22(1):89–95. doi: 10.1016/j.breast.2012.09.013. PMID: 23127278.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0681-2053
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8370-1835
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8845fbac7b3b3f83d1b18b12c0c510c7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91e6ef16916ce047a7f39512c52c6319
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5a628536d39cea9ccaa553272916dd1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b0176f2c8669a6041c36d85b8f2b475
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_707edd38410d99d115e358bb186434ba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eba97546362ae2f706a1d4c9370c23e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87459212fa475c49c0c4569d0697641f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d5219ec8536fa9ed94708508e968c40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f12198c39bee7b045b8fa9b2b0779bc6
date 201302
identifier https://doi.org/10.1016/j.breast.2012.09.013
https://pubmed.ncbi.nlm.nih.gov/23127278
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31740
https://portal.issn.org/resource/ISSN/0960-9776
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Immunohistochemical study of pElk-1 expression in human breast cancer: Association with breast cancer biologic profile and clinicopathologic features
discusses http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0028859
http://id.nlm.nih.gov/mesh/M0018586
http://id.nlm.nih.gov/mesh/M0029612
http://id.nlm.nih.gov/mesh/M0495206
http://id.nlm.nih.gov/mesh/M0472002
http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0502630
http://id.nlm.nih.gov/mesh/M0164561
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D050807Q000378
http://id.nlm.nih.gov/mesh/D014408Q000378
http://id.nlm.nih.gov/mesh/D001943Q000378
http://id.nlm.nih.gov/mesh/D018270Q000378
http://id.nlm.nih.gov/mesh/D018275Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D007150
http://id.nlm.nih.gov/mesh/D001943Q000401
http://id.nlm.nih.gov/mesh/D018719Q000378
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D011960Q000378
http://id.nlm.nih.gov/mesh/D001943Q000473
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D019938Q000378
http://id.nlm.nih.gov/mesh/D018270Q000473
http://id.nlm.nih.gov/mesh/D018275Q000401
http://id.nlm.nih.gov/mesh/D018275Q000473
http://id.nlm.nih.gov/mesh/D010766
http://id.nlm.nih.gov/mesh/D018270Q000401
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D019394Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_49b5c476d44358353918078a973c7d04
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1afa113b0d884f36154ce9339375de8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8382
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7101
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a95421c679462609c9ef4e68005e1dcc
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2002

Total number of triples: 69.